EN
HI
Beryl Drugs share price chart
Beryl Drugs Share Key Metrics
Volume
1731.00
Market Cap
11.76 CR
LTQ@LTP
141@22.55
ATP
22.95
Var Margin
31.68 %
Circuit Range
18.7-28.04
Delivery %
55.4 %
Value
39726.45
ASM/GSM
No
Market Lot
1
Summary
BERLDRG stock price is ₹22.55 as of 14 Aug, 2026. The stock intraday movement has stayed between ₹22.15 and ₹23.96, while Beryl Drugs share price 52 week high low is ₹15.92 & ₹30.00.
In terms of trading activity, BERLDRG share price has recorded a volume of 1,731 shares. The Beryl Drugs has a market cap of ₹5071700. The stock’s Average Traded Price (ATP) stands at ₹22.95, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 141 @ ₹22.55.
The Beryl Drugs upper circuit limit is ₹28.04 & The Beryl Drugs lower circuit limit is ₹18.70, with a Value of ₹39726.45. The Delivery Percentage for the day is 55.4%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Beryl Drugs Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
64.16
Sector P/B
3.28
Sec. Div. Yield
0.51
Beryl Drugs Resistance and Support
Pivot 23.44
Resistance
First Resistance
24.62
Second Resistance
25.88
Third Resistance
27.06
Support
First Support
22.18
Second Support
21
Third Support
19.74
Beryl Drugs Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Aug 13 2026 | 22.15 | 22.55 | -3.51% | 23.96 | 22.15 |
| Wed Aug 12 2026 | 24.7 | 23.37 | -2.62% | 24.7 | 22.26 |
| Tue Aug 11 2026 | 24.54 | 24 | -0.25% | 24.54 | 22.06 |
Beryl Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-06-16 | Others |
| 2026-05-28 | Audited Results |
| 2026-04-01 | Notice of EGM & Others |
| 2026-02-09 | Quarterly Results |
| 2026-01-03 | Others |
| 2025-11-13 | Quarterly Results |
| 2025-09-02 | A.G.M. |
| 2025-08-07 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-08 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Beryl Drugs News
Beryl Drugs Ltd - 524606 - Board Meeting Outcome for OUTCOME OF BOARD MEETING
Beryl Drugs' Board approved the unaudited financial results for the quarter ended June 30, 2026. The Limited Review Report by auditors for the same period was taken on record, and the board also discussed the company's books of accounts.
Aug 11 2026 17:06:02
Beryl Drugs Ltd - 524606 - Board Meeting Intimation for Consider And Approve The Unaudited Financial Results For The Quarter Ended 30Th June, 2026
Beryl Drugs has scheduled a Board meeting for August 11, 2026. The primary agenda includes considering and approving the unaudited financial results for the first quarter of FY27, ended June 30, 2026.
Aug 05 2026 15:04:24
Beryl Drugs Management
| Name | Position |
|---|---|
| Sanjay Sethi | Managing Director |
| Sudhir Sethi | Chairman |
Beryl Drugs Similar Stocks
Bacil Pharma Ltd.
13.81
-0.72 (4.96%)
Cian Healthcare Ltd.
9.55
0.00 (0.00%)
Ishita Drugs & Industries Ltd.
71.00
-1.26 (1.74%)
Emmessar Biotech & Nutrition Ltd.
23.75
0.13 (0.55%)
Sharma East India Hospitals & Medical Research Ltd
100.98
0.48 (0.48%)
Norris Medicines Ltd.
16.31
0.06 (0.37%)
Soni Medicare Ltd.
72.99
0.00 (0.00%)
Parmax Pharma Ltd.
115.45
2.25 (1.99%)
Colinz Laboratories Ltd.
83.25
1.75 (2.15%)
Beryl Drugs FAQs
The Buying Price of Beryl Drugs share is 22.55 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Beryl Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Beryl Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Beryl Drugs shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Beryl Drugs shares is 0. Useful to assess the stock's value relative to its book value.
To assess Beryl Drugs’s valuation compare Sector P/E, P/B which are 64.16 & 3.28 with sector averages, along with growth rates and financial metrics.
The Market Cap of Beryl Drugs is 11.76 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Beryl Drugs share price is 30.00 & 15.92. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Beryl Drugs belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
